More employers and health care payers are carving out their pharmacy benefit management as they seek more transparency.
As members of Congress decide how to expand access to telehealth after the pandemic, one of the biggest questions has centered around how much Medicare providers should be paid for virtual care.
Many on the frontlines are not just tired but are also in precarious financial straits and lack the resources to “build back better.”
Democrats’ next big bill could include drug price negotiations and other industry curbs. Pharma may not be able to fight it off this time.
Under unprecedented economic pressures due to the pandemic large employers are looking for new ways to buy the best quality health care for their employees.
“I have no doubt that it’s going to be a pretty epic fight.”
The nation’s roughly 6,000 hospitals have begun to reveal the secret rates they negotiate with insurers for a range of procedures.
Lawmakers banned surprise billing by including language in the massive COVID relief and federal spending package.
Powerful health systems have historically obfuscated pricing data to pad profits.
The financial pressures created by COVID-19 are aggravating the already-enormous challenge of managing soaring healthcare costs.